scispace - formally typeset
R

Rodney J. Landreneau

Researcher at Allegheny General Hospital

Publications -  77
Citations -  4110

Rodney J. Landreneau is an academic researcher from Allegheny General Hospital. The author has contributed to research in topics: Lung cancer & Thoracoscopy. The author has an hindex of 36, co-authored 77 publications receiving 3960 citations. Previous affiliations of Rodney J. Landreneau include Allegheny University of the Health Sciences & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer

TL;DR: Wedge resection, done by open thoracotomy or video-assisted techniques, appears to be a viable "compromise" surgical treatment of stage I (T1 N0 M0) non-small-cell lung cancer for patients with cardiopulmonary physiologic impairment.
Journal ArticleDOI

Segmental resection spares pulmonary function in patients with stage I lung cancer

TL;DR: For patients with stage I non-small cell lung cancer, segmental resection offers preservation of pulmonary function compared with lobectomy and does not compromise survival.
Journal ArticleDOI

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

TL;DR: High VEGF expression, tumor size, and angiolymphatic invasion emerged as three independent factors predicting worsening prognosis using multivariate analysis.
Journal ArticleDOI

Long-term outcome after resection for bronchial carcinoid tumors

TL;DR: Either major lung resection or wedge resection is appropriate treatment for patients with early stage typical bronchial carcinoid tumors regardless of histological subtype, suggesting that a formal resection may improve long-term outcome.
Journal ArticleDOI

p53 Sequence Analysis Predicts Treatment Response and Outcome of Patients with Esophageal Carcinoma

TL;DR: In this article, the authors examined whether alterations of the p53 gene correlate with clinicopathologic parameters, response to preoperative chemotherapy/radiotherapy, and outcome in patients with esophageal carcinoma.